An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia.
暂无分享，去创建一个
V. Petrizzi | E. Vismara | M. Montillo | F. Ilariucci | I. Attolico | M. Crugnola | M. Spriano | A. Zaccaria | P. Spedini | L. Uziel | Francesca Ricci | Alessandra Tedeschi | E. Morra | Angelo De Blasio